FORTE BIOSCIENCES, INC. Debt Securities, Available-for-sale, Amortized Cost
FORTE BIOSCIENCES, INC. (FBRX) had Debt Securities, Available-for-sale, Amortized Cost of $36.11 million as of 2024-12-31, per its 10-Q filed 2025-08-14.
Financial Statements › Notes
us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis · last filed 2025-08-14
- 2024-12-31: Debt Securities, Available-for-sale, Amortized Cost $36.11M.
- 2024-09-30: Debt Securities, Available-for-sale, Amortized Cost $10.00M.
- 2024-06-30: Debt Securities, Available-for-sale, Amortized Cost $14.93M.
- 2024-03-31: Debt Securities, Available-for-sale, Amortized Cost $19.81M.
| Period end | Debt Securities, Available-for-sale, Amortized Cost |
|---|---|
| 2024-12-31 | $36.11M 10-Q · filed 2025-08-14 |
| 2024-09-30 | $10.00M 10-Q · filed 2024-11-14 |
| 2024-06-30 | $14.93M 10-Q · filed 2024-08-14 |
| 2024-03-31 | $19.81M 10-Q · filed 2024-05-13 |
| 2023-12-31 | $25.16M 10-K · filed 2025-03-28 |
| 2023-09-30 | $25.05M 10-Q · filed 2023-11-13 |
| 2019-12-31 | $12.82M 10-Q · filed 2020-04-23 |
| 2019-09-30 | $29.72M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $49.37M 10-Q · filed 2019-08-08 |
| 2019-03-31 | $49.11M 10-Q · filed 2019-05-07 |
| 2018-12-31 | $55.30M 10-K · filed 2020-02-27 |
| 2018-09-30 | $56.39M 10-Q · filed 2018-11-08 |
| 2018-06-30 | $54.90M 10-Q · filed 2018-08-09 |
| 2018-03-31 | $56.31M 10-Q · filed 2018-05-11 |
| 2017-12-31 | $52.82M 10-K · filed 2019-02-27 |
| 2017-09-30 | $24.73M 10-Q · filed 2017-11-08 |
| 2017-06-30 | $32.55M 10-Q · filed 2017-08-09 |
| 2017-03-31 | $21.93M 10-Q · filed 2017-05-23 |
| 2016-12-31 | $25.73M 10-K · filed 2018-03-09 |